Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(-18.75%)
USD 0.07
(-18.75%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 543.34 Thousand CAD | -87.63% |
| 2023 | 4.39 Million CAD | -36.1% |
| 2022 | 6.87 Million CAD | 732.97% |
| 2021 | 825.48 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.09 Million CAD | 21.67% |
| 2024 Q4 | 543.34 Thousand CAD | -50.18% |
| 2024 Q2 | 896.47 Thousand CAD | -79.85% |
| 2024 FY | 543.34 Thousand CAD | -87.63% |
| 2024 Q1 | 4.44 Million CAD | 1.24% |
| 2023 Q4 | 4.39 Million CAD | -24.17% |
| 2023 FY | 4.39 Million CAD | -36.1% |
| 2023 Q3 | 5.79 Million CAD | 13.1% |
| 2023 Q2 | 5.12 Million CAD | -33.59% |
| 2023 Q1 | 7.71 Million CAD | 12.18% |
| 2022 Q2 | 9.94 Million CAD | 147.84% |
| 2022 FY | 6.87 Million CAD | 732.97% |
| 2022 Q1 | 4.01 Million CAD | 386.08% |
| 2022 Q3 | 10.73 Million CAD | 7.97% |
| 2022 Q4 | 6.87 Million CAD | -35.96% |
| 2021 Q4 | 825.48 Thousand CAD | 0.0% |
| 2021 FY | 825.48 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bioxytran, Inc. | 137.63 Thousand USD | -294.765% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 98.601% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -611.614% |
| SQZ Biotechnologies Company | 107.18 Million USD | 99.493% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 62.058% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 94.852% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 99.583% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -650.841% |
| Marizyme, Inc. | 22.01 Million USD | 97.532% |
| Genus plc | 1.02 Billion USD | 99.947% |
| Pharming Group N.V. | 462.85 Million USD | 99.883% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 83.6% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -8.878% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | 13.342% |
| ContraFect Corporation | 20.67 Million USD | 97.372% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -42.171% |
| IMV Inc. | 31.33 Million USD | 98.266% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 86.895% |
| ONE Bio Corp. | 70.08 Million USD | 99.225% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 99.577% |
| Mesoblast Limited | 667.9 Million USD | 99.919% |
| MultiCell Technologies, Inc. | 126.22 USD | -430375.36% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 98.455% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.984% |
| Neon Bloom, Inc. | 770.64 Thousand USD | 29.495% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -107.958% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 92.474% |
| Biomind Labs Inc. | 73.81 Thousand USD | -636.052% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 62.498% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 98.19% |
| Skye Bioscience, Inc. | 11.94 Million USD | 95.45% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | 60.0% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 80.216% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -39.189% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 72.253% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | 20.966% |
| Accustem Sciences Inc. | 939.68 Thousand USD | 42.178% |
| EV Biologics, Inc. | 431.71 Thousand USD | -25.858% |
| Q BioMed Inc. | 3.51 Million USD | 84.544% |
| GB Sciences, Inc. | 103.44 Thousand USD | -425.266% |
| Alpha Cognition Inc. | 2.45 Million USD | 77.842% |
| CSL Limited | 38.02 Billion USD | 99.999% |
| Agentix Corp. | 261.39 Thousand USD | -107.866% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.878% |
| Enzolytics Inc. | 361.7 Million USD | 99.85% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 8.11 Million USD | 93.304% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 71.066% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 79.128% |
| argenx SE | 4.54 Billion USD | 99.988% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 98.056% |
| HST Global, Inc. | 1526.00 USD | -35505.898% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 98.861% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | 45.004% |
| Halberd Corporation | 10.13 Thousand USD | -5263.202% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | 15.057% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 93.929% |
| Zenith Capital Corp. | 7410.00 USD | -7232.605% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -2285.084% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -68.843% |
| AVAX Technologies, Inc. | 7.37 Million USD | 92.635% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -107.889% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | 41.447% |
| Ember Therapeutics, Inc. | 184.00 USD | -295196.739% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -772.873% |
| Helix BioMedix, Inc. | 3.02 Million USD | 82.039% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 98.969% |
| Kadimastem Ltd | 2.3 Million USD | 76.418% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | 96.268% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -851.669% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -23421.472% |
| LadRx Corporation | 2.3 Million USD | 76.457% |
| Cell Source, Inc. | 195.17 Thousand USD | -178.395% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -13.066% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -53.654% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -53.654% |
| Affymax, Inc. | 7.44 Million USD | 92.7% |
| Mobile Lads Corp. | 52.00 USD | -1044796.154% |
| Itoco Inc. | 1.4 Million USD | 61.192% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -468.015% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -412.591% |
| International Stem Cell Corporation | 5.39 Million USD | 89.919% |
| CytoDyn Inc. | 11.13 Million USD | 95.121% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -280.037% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -2938.848% |
| Qrons Inc. | 420.00 USD | -129268.095% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -40.956% |
| SYBLEU INC | 330.46 Thousand USD | -64.417% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | 1.589% |
| Rebus Holdings, Inc. | 5000.00 USD | -10766.92% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -32.711% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 96.378% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 96.723% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -587.78% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | 37.162% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 92.772% |
| Neutra Corp. | 2851.00 USD | -18958.085% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 98.323% |
| PureTech Health plc | 693.97 Million USD | 99.922% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 93.268% |
| IXICO plc | 15.84 Million USD | 96.571% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 93.439% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.474% |
| CSL Limited | 38.02 Billion USD | 99.999% |
| Cellectis S.A. | 333.99 Million USD | 99.837% |